Eurofins Scientific SE (EPA: ERF)
France
· Delayed Price · Currency is EUR
46.45
+0.59 (1.29%)
Nov 21, 2024, 12:55 PM CET
Eurofins Scientific SE Revenue
Eurofins Scientific SE had revenue of 3.42B EUR in the half year ending June 30, 2024, with 0.21% growth. This brings the company's revenue in the last twelve months to 6.72B, up 3.28% year-over-year. In the year 2023, Eurofins Scientific SE had annual revenue of 6.51B, down -2.94%.
Revenue (ttm)
6.72B
Revenue Growth
+3.28%
P/S Ratio
1.32
Revenue / Employee
108.80K
Employees
61,798
Market Cap
8.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.51B | -197.50M | -2.94% |
Dec 31, 2022 | 6.71B | -5.60M | -0.08% |
Dec 31, 2021 | 6.72B | 1.28B | 23.51% |
Dec 31, 2020 | 5.44B | 876.00M | 19.20% |
Dec 31, 2019 | 4.56B | 781.70M | 20.67% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Ipsen S.A. | 3.44B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |
Vetoquinol SA | 537.47M |
Eurofins Scientific SE News
- 4 weeks ago - Eurofins Scientific SE (ERFSF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Eurofins Scientific: On Track To Generate 1.5B EUR In EBITDA - Seeking Alpha
- 4 months ago - Eurofins Scientific SE (ERFSF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Eurofins Scientific announces the acquisition of Labormar, further expanding its presence in Latin America and its Food and Feed, Environmental, Cosmetic and Pharmacological testing offering in Colombia - Business Wire
- 5 months ago - Eurofins Scientific's stock drops on allegations from short-seller Muddy Waters - Market Watch
- 7 months ago - Eurofins Scientific SE (ERFSF) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Eurofins Scientific SE (ERFSF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 10 months ago - Eurofins Scientific Is A Growth Story That Has Reached Fair Valuation Again - Seeking Alpha